Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Home
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • ATMP
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Product information
    • Regulatory procedures
  • Veterinary
  • CPD supplements
    • Back to parent navigation item
    • CPD supplements
    • 2021/2022
    • 2020
    • 2019
  • Interviews
  • Meeting reports
    • Back to parent navigation item
    • Meeting reports
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Human Medicines
      • Medical Devices/IVDs
      • Veterinary Medicines
      • Annual Lecture
  • Editorials
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Home
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
    • AdobeStock_264649866
      Translating digitalisation trends into tangible solutions
    • AdobeStock_474265160
      What can past decision-making data tell us about how the FDA will make future combination product categorisation decisions?
    • AdobeStock_405906571-min
      Practical insights into the recent EU MDR framework
  • Pharmaceuticals
      • ATMP
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Product information
      • Regulatory procedures
    • AdobeStock_393791829
      Data governance as a strategic imperative for regulatory compliance
    • AdobeStock_286032180
      Exploring Amgen’s Project Orbis experience with sotorasib (Part 2)
    • AdobeStock_244609855
      A regulatory view on the change management process for medicinal products
  • Veterinary
  • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • AdobeStock_507759233
      FDA meetings: How to hold a successful meeting across the drug development lifecycle
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
    • AdobeStock_207448226
      Digital health technologies – an overview of EU and US frameworks
  • Interviews
  • Meeting reports
      • Symposium 2022
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
      • Symposium 2021
        • Human Medicines
        • Medical Devices/IVDs
        • Veterinary Medicines
        • Annual Lecture
    • 5M4A11193_TOPRA Symposium 2022_Day 1_20221017
      HM3: Lessons learned and strategic priorities
    • [FROM LEFT] Claudia Popp, Olga Tkachenko and Marta Carnielli
      IVD1: Current state –
      and update on IVDR implementation
    • 5M4A2062_TOPRA Symposium 2022_Day 2_20221018
      VM2: Novel therapies in animal health – Balancing guidance versus gaining flexibility
  • Editorials
  • More navigation items

Clinical trials stories

  • AdobeStock_505106152 (3)

    Inclusion of older people in drug development and clinical trials: Part 2

    2022-09-16T09:25:00+01:00By Kajal Patel

  • Older-People-HERO

    Inclusion of older people in drug development and clinical trials: Part 1

    2022-08-22T00:01:00+01:00By Kajal Patel

  • Data-Remed-HERO (002)

    How data remediation and stewardship is becoming a standard responsibility for regulatory operations professionals

    2022-08-22T00:01:00+01:00By Jacci Squire

  • AdobeStock_439443935

    On the path to adoption of decentralised clinical trials

    2021-12-23T10:38:00+00:00By Wendi M Lau

  • clinical trial

    Clinical Trial Information System: overview, opportunities and challenges

    2021-12-23T09:10:00+00:00By Giulia Detela, Angela Nelson, Rina Kacha, Tijana Pajic, Marko Drobec, Aneta Tsolovska, Tsvetelina Popova

  • wheelchair professional

    A regulatory lens on an industry imperative: Diversity in clinical research

    2021-12-23T11:11:00+00:00By Aman Khera, Sarah Bly

  • Editorial board
  • Future focus topics
  • Glossary
  • Privacy policy
  • Search the archive
  • TOPRA membership
  • What is regulatory affairs?
  • ISSN 1742-8955

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium Tel: +32 (0) 2 808 72 70

  • Issues
  • Contact us
  • Topics A-Z
  • Contributors A-Z
  • © 2023 Regulatory Rapporteur

Site powered by Webvision Cloud